Skip to content

The effect of low-dose esketamine on postoperative fatigue in gynecological laparoscopic surgery patients

The effect of low-dose esketamine on postoperative fatigue in gynecological laparoscopic surgery patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112382
Enrollment
Unknown
Registered
2025-11-13
Start date
2025-11-14
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative fatigue

Interventions

Experimental group:Intraoperative infusion of low-dose esketamine
Control group:Intraoperative infusion of an equivalent volume of normal saline

Sponsors

The Third Affiliated Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Meet the indications for gynecological laparoscopic surgery; 2.Age 18–65 years; 3.ASA classification I or II; 4.No significant preoperative psychiatric abnormalities;

Exclusion criteria

Exclusion criteria: 1.Patients with ASA classification III or higher; 2.History of unstable angina or myocardial infarction within the past 3 months; 3.Contraindications or allergies to the trial drugs or other anesthetics, including untreated or inadequately treated hyperthyroidism, uncontrolled or untreated hypertension (resting blood pressure >180/100 mmHg); 4.Patients with congestive heart failure; 5.Significant preoperative liver or kidney dysfunction; 6.Increased intracranial pressure or central nervous system injury/disease; 7.Body mass index (BMI) 30 kg/m^2; 8.Participation in other clinical trials within one month before the start of this study;

Design outcomes

Primary

MeasureTime frame
Postoperative Fatigue Incidence;

Secondary

MeasureTime frame
Pittsburgh sleep quality index,PSQI;QoR-15 (Quality of Recovery-15) Score;Visual Analogue Scale (VAS);The incidence of adverse reactions;Intraoperative consumption of etomidate and remifentanil;Steward score after extubation;

Countries

China

Contacts

Public ContactSong Fuhu

The Third Affiliated Hospital of Southern Medical University

songfuhu@126.com+86 20 6278 4240

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 28, 2026